
REMINDER: A doctor&rsquo,s prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order (before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to OnlinePharmacy@watsons.com.ph with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.
Treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response to one or more disease-modifying anti-rheumatic drug (DMARDs).
Place of Origin
Germany
Product Usage
Tofacitinib (Xeljanz/Xeljanz XR) has not been studied and use should be avoided in combination with TNF antagonists, IL-1R antagonists, IL-6R antagonists, anti-CD20 monoclonal antibodies, IL-17 antagonists, IL-12/IL23 antagonists, anti-integrins, and selective co-stimulation modulators and potent immunosuppressants, such as azathioprine, cyclosporine, and tacrolimus because of the possibility of increased immunosuppression and increased risk of infection. Tofacitinib (Xeljanz/Xeljanz XR) treatment should be interrupted if a patient develops a serious infection until the infection is controlled.It is given orally with or without food.
Ingredients
Tofacitinib
Warnings
Special Warnings and Precaution for Use: Tofacitinib (Xeljanz/Xeljanz XR) should not be initiated in patients with an active infection; including localized infections. The risks and benefits of treatment should be considered prior to initiating Tofacitinib (Xeljanz/Xeljanz XR) in patients with chronic or recurrent infections
Width
1
Height
1
Depth
1